Biomarin Pharmaceutical (BMRN) EV to EBIT (2010 - 2026)
Biomarin Pharmaceutical's (BMRN) EV to EBIT was 68.34 for Q2 2026, up 481.4% from 11.75 a year earlier and up 147.7% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EV to EBIT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biomarin Pharmaceutical's EV to EBIT came in at 33.09, up 344.2% year-over-year; for FY2025, it was 24.10, up 2.3% from FY2024.
- By year, EV to EBIT came in at 23.55 in FY2024 (-74.4%), 92.11 in FY2023 (-17.6%) and 111.72 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly EV to EBIT since Q1 2024.
- Year over year, EV to EBIT has now increased in each of the last three quarters, with growth averaging 21.4% over the last eight quarters.
- The high point for year-over-year EV to EBIT in five years was Q2 2026 (growth of 481.4%); the low point was Q2 2025 (a decline of 78.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 27.58 (Q1 2026), 24.10 (Q4 2025) and 14.50 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.34 |
| Mar 31, 2026 | 27.58 |
| Dec 31, 2025 | 24.10 |
| Sep 30, 2025 | 14.50 |
| Jun 30, 2025 | 11.75 |
| Mar 31, 2025 | 19.82 |
| Dec 31, 2024 | 23.55 |
| Sep 30, 2024 | 35.60 |
| Jun 30, 2024 | 54.17 |
| Mar 31, 2024 | 73.31 |
| Dec 31, 2023 | 92.11 |
| Sep 30, 2023 | 106.86 |
| Jun 30, 2023 | 134.60 |
| Mar 31, 2023 | 198.61 |
| Dec 31, 2022 | 111.72 |
| Sep 30, 2022 | 133.84 |
| Jun 30, 2022 | 248.50 |
| Mar 31, 2022 | 441.46 |
| Jun 30, 2020 | 356.12 |
| Mar 31, 2020 | 246.62 |
API Access
Biomarin Pharmaceutical EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();